{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:38:45Z","timestamp":1773797925512,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>We report a rare case of multiple primary tumors in a 67-year-old male. The patient was treated surgically for a lumbar disc herniation with intraoperative findings of L5 nerve root tumor, and postoperative pathology confirmed a diagnosis of diffuse large B-cell lymphoma (DLBCL). Three months later, the patient was further pathologically diagnosed with prostate cancer. The multidisciplinary treatment team devised a staged therapeutic strategy: firstly, 2 cycles of R-CHOP chemotherapy for DLBCL, followed by local radiotherapy for the residual lesion of lumbar spine tumor, and then 2 cycles of R-MTX-CHOP chemotherapy in sequence; after the DLBCL was controlled, the patient underwent radical prostatectomy, which was followed by adjuvant endocrine therapy and pelvic lymph node radiotherapy. Post-treatment evaluation showed complete remission (CR) in both tumors. After five years of disease-free survival, the patient presented with enlarged cervical lymph nodes in October 2022. A biopsy confirmed DLBCL recurrence. The treatment team administered six cycles of R-GemOx chemotherapy, followed by maintenance therapy with the targeted agent Orelabrutinib. Subsequent assessments confirmed a second CR. In September 2024, a colonoscopy revealed a rectal tumor, which was pathologically diagnosed as rectal cancer. The patient underwent radical surgery, and the pathological staging was determined to be stage I. According to the literature search, this is the first reported case of triple primary malignancies involving DLBCL, prostate cancer and rectal cancer, which provides valuable experience in the clinical diagnosis and treatment of such rare cases.<\/jats:p>","DOI":"10.3389\/fonc.2025.1561923","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:27:51Z","timestamp":1750138071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse large B-cell lymphoma combined with two solid tumors: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiufang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaojun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.25482","article-title":"Multiple primary Malignant tumors - A clinical analysis of 15,321 patients with Malignancies at a single center in China","volume":"9","author":"Zhai","year":"2018","journal-title":"J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196103\/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6","article-title":"Multiple primary Malignant neoplasms. I. Introduction and presentation of data","volume":"14","author":"Moertel","year":"1961","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000421-200302000-00015","article-title":"Multiple primary Malignant neoplasms: case report and a comprehensive review of the literature","volume":"26","author":"Demandante","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101682","article-title":"Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenstrom\u2019s macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study","volume":"52","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01482-5","article-title":"Orelabrutinib: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26826","article-title":"Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study","volume":"98","author":"Xu","year":"2023","journal-title":"Am J Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01231-w","article-title":"Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis","volume":"23","author":"Wei","year":"2023","journal-title":"Clin Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn121090-20240607-00212","article-title":"Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting","volume":"45","author":"Yin","year":"2024","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(93)90187-e","article-title":"Germ-line p53 mutation is uncommon in patients with triple primary cancers","volume":"73","author":"Shiseki","year":"1993","journal-title":"Cancer Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"B11","volume-title":"BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. [Review; Book Chapter]","author":"Petrucelli","year":"1993"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.08.058","article-title":"Lynch syndrome genetics and clinical implications","volume":"164","author":"Peltomaki","year":"2023","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.2185","article-title":"BRCA1, BRCA2, and associated cancer risks and management for male patients: A review","volume":"10","author":"Cheng","year":"2024","journal-title":"JAMA Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2007.12.007","article-title":"Immune surveillance: a balance between protumor and antitumor immunity","volume":"18","author":"Ostrand-Rosenberg","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000512326","article-title":"Immune system efficiency in cancer and the microbiota influence","volume":"88","author":"Barbosa","year":"2021","journal-title":"Pathobiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington","year":"2011","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/HP.0000000000000013","article-title":"Second Malignant neoplasms and cardiovascular disease following radiotherapy","volume":"106","author":"Travis","year":"2014","journal-title":"Health Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-021-04075-6","article-title":"Prostate radiotherapy and the risk of secondary rectal cancer-a meta-analysis","volume":"37","author":"Nugent","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196611000-00001","article-title":"Incidence of multiple primary cancers per man-year of follow up: 20-year review from the Ellis Fischel State Cancer Hospital","volume":"164","author":"Spratt","year":"1966","journal-title":"Ann Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-006-0600-8","article-title":"The risk of multiple primary Malignancies with colorectal carcinoma","volume":"49","author":"Yamamoto","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"B22","article-title":"Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin","volume":"5","author":"Gallagher","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1055\/a-1216-7050","article-title":"Smoking tobacco and cancer risk","volume":"146","author":"Scherubl","year":"2021","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1561923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:27:52Z","timestamp":1750138072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1561923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":23,"alternative-id":["10.3389\/fonc.2025.1561923"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1561923","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1561923"}}